Novo Nordisk A/S - 25a-B
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Denmark
- Registered address
- Brennum Park 25A, Hilleroed, Hovedstaden 3400, Denmark (DNK)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3003131673 · DUNS 309477891
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-11-04
- VAIDrug Quality Assurance2018-06-14
- VAIBlood and Blood Products2016-01-22
- NAIDrug Quality Assurance2014-10-10
- VAIDrug Quality Assurance2012-03-21
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- liraglutidein shortageNovo Nordisk Pharmaceutical Industries, LP
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.